المؤلفون: Rouger-Gaudichon, Jérémie, Bertrand, Yves, Boissel, Nicolas, Brethon, Benoît, Ducassou, Stéphane, Gandemer, Virginie, Halfon-Domenech, Carine, Leblanc, Thierry, Leverger, Guy, Michel, Gérard, Petit, Arnaud, Ray-Lunven, Anne-France, Rohrlich, Pierre-Simon, Schneider, Pascale, Sirvent, Nicolas, Strullu, Marion, Baruchel, André

المساهمون: Institut de Génétique et Développement de Rennes (IGDR), Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Hospices Civils de Lyon (HCL), Hôpital Robert Debré Paris, Hôpital Robert Debré, CHU Bordeaux, Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou, CHU Trousseau APHP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital de la Timone CHU - APHM (TIMONE), Centre Hospitalier Universitaire de Nice (CHU Nice), Service d'hémato-immuno-oncologie pédiatrique Rouen, CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Université de Montpellier (UM)

المصدر: ISSN: 0007-4551.

مصطلحات موضوعية: Acute lymphoblastic leukemia, Adolescents, COVID 19, Children, SARS-CoV-2, MESH: Adenosine Monophosphate, MESH: Adolescent, MESH: COVID-19 Vaccines, MESH: Cancer Care Facilities, MESH: Consolidation Chemotherapy, MESH: Child, MESH: Drug Interactions, MESH: France, MESH: Humans, MESH: Induction Chemotherapy, MESH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, MESH: Maintenance Chemotherapy, MESH: Recurrence, MESH: Precursor Cell Lymphoblastic Leukemia-Lymphoma, MESH: Risk Assessment, MESH: Adrenal Cortex Hormones, MESH: Societies, Medical, MESH: Alanine, MESH: Antiviral Agents, MESH: COVID-19, MESH: COVID-19 Nucleic Acid Testing

Relation: info:eu-repo/semantics/altIdentifier/pmid/33781551; hal-03664137; https://hal.science/hal-03664137; https://hal.science/hal-03664137/document; https://hal.science/hal-03664137/file/S0007455121000825.pdf; PII: S0007-4551(21)00082-5; PUBMED: 33781551; PUBMEDCENTRAL: PMC7951944; WOS: 000652032900009

الاتاحة: https://hal.science/hal-03664137
https://hal.science/hal-03664137/document
https://hal.science/hal-03664137/file/S0007455121000825.pdf
https://doi.org/10.1016/j.bulcan.2021.02.004

المؤلفون: Barbieux, Claire, Bonnet Des Claustres, Mathilde, de La Brassinne, Michel, Bricteux, Guy, Bagot, Martine, Bourrat, Emmanuelle, Hovnanian, Alain

المساهمون: Genetic skin diseases : from disease mechanism to therapies (Equipe Inserm U1163), Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Université de Liège, Service de Dermatologie AP-HP Hôpital Saint-Louis, Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Cité (UPCité), Service de génétique moléculaire CHU Necker, Hôpital Necker - Enfants Malades AP-HP, ANR-17-CE14-0025,Tfh-Atopy,Différentiation et rôle pathogénique des lymphocytes T auxiliaires folliculaires dans la marche atopique(2017), ANR-19-CE17-0017,TARGET-NS,Développement d'une nouvelle biothérapie ciblant les mécanismes inflammatoires du syndrome de Netherton(2019), ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010)

المصدر: ISSN: 0190-9622.

مصطلحات موضوعية: MESH: Administration, Cutaneous, MESH: Adult, MESH: Humans, MESH: Induction Chemotherapy, MESH: Injections, Subcutaneous, MESH: Maintenance Chemotherapy, MESH: Male, MESH: Netherton Syndrome, MESH: Severity of Illness Index, MESH: Skin, MESH: Treatment Outcome, MESH: Young Adult, MESH: Antibodies, Monoclonal, Humanized, MESH: Combined Modality Therapy, MESH: Female, MESH: Glucocorticoids, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology

Relation: info:eu-repo/semantics/altIdentifier/pmid/32692997; PUBMED: 32692997

الاتاحة: https://hal.science/hal-03543139
https://hal.science/hal-03543139v1/document
https://hal.science/hal-03543139v1/file/S0190962220322246.pdf
https://doi.org/10.1016/j.jaad.2020.07.054

المؤلفون: Canali, Alban, Vergnolle, Inès, Bertoli, Sarah, Largeaud, Laetitia, Nicolau, Marie-Laure, Rieu, Jean-Baptiste, Tavitian, Suzanne, Huguet, Françoise, Picard, Muriel, Bories, Pierre, Vial, Jean Philippe, Lechevalier, Nicolas, Béné, Marie Christine, Luquet, Isabelle, Mansat-de Mas, Véronique, Delabesse, Eric, Récher, Christian, Vergez, François

المساهمون: Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: ISSN: 1078-0432.

مصطلحات موضوعية: MESH: Humans, MESH: Prognosis, MESH: Leukemia, Myeloid, Acute, MESH: Induction Chemotherapy, MESH: Neoplasm, Residual, MESH: Stem Cells, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/36318706; PUBMED: 36318706

الاتاحة: https://hal.science/hal-04783847
https://doi.org/10.1158/1078-0432.CCR-22-2237

المؤلفون: Fumery, Mathurin, Defrance, Antoine, Roblin, Xavier, Altwegg, Romain, Caron, Benedicte, Hébuterne, Xavier, Stefanescu, Carmen, Meyer, Antoine, Nachury, Maria, Laharie, David, Nancey, Stephane, Le Berre, Catherine, Serrero, Melanie, Geyl, Sophie, Giletta, Cyrielle, Ah-Soune, Philippe, Duveau, Nicolas, Uzzan, Mathieu, Abitbol, Vered, Biron, Amelie, Tran-Minh, My-Linh, Paupard, Thierry, Vuitton, Lucine, Elgharabawy, Yasmine, Peyrin-Biroulet, Laurent, Tran-Minh, My‐linh

المساهمون: Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service d'Hépato-gastro-entérologie CHRU Nancy, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)

المصدر: ISSN: 0953-0673.

مصطلحات موضوعية: Crohn’s disease, effectiveness, induction therapy, risankizumab, MESH: Humans, MESH: Crohn Disease, MESH: Ustekinumab, MESH: Induction Chemotherapy, MESH: Retrospective Studies, MESH: Tumor Necrosis Factor Inhibitors, MESH: Remission Induction, MESH: Treatment Outcome, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/36534763; hal-04167939; https://hal.univ-lorraine.fr/hal-04167939; PUBMED: 36534763

الاتاحة: https://hal.univ-lorraine.fr/hal-04167939
https://doi.org/10.1111/apt.17358

المؤلفون: d'Haens, Geert, Panaccione, Remo, Baert, Filip, Bossuyt, Peter, Colombel, Jean-Frederic, Danese, Silvio, Dubinsky, Marla, Feagan, Brian, Hisamatsu, Tadakazu, Lim, Allen, Lindsay, James, Loftus, Edward, Panés, Julian, Peyrin-Biroulet, Laurent, Ran, Zhihua, Rubin, David, Sandborn, William, Schreiber, Stefan, Neimark, Ezequiel, Song, Alexandra, Kligys, Kristina, Pang, Yinuo, Pivorunas, Valerie, Berg, Sofie, Duan, W Rachel, Huang, Bidan, Kalabic, Jasmina, Liao, Xiaomei, Robinson, Anne, Wallace, Kori, Ferrante, Marc

المساهمون: Amsterdam University Medical Centers (Amsterdam UMC), University of Calgary, AZ Delta, Imelda General Hospital, Mount Sinai School of Medicine, Department of Psychiatry-Icahn School of Medicine at Mount Sinai New York (MSSM), Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University Milan, Italie (UniSR), IRCCS San Raffaele Hospital, University of Western Ontario (UWO), Kyorin University School of Medicine Tokyo, Japan, Kyorin University Tokyo, Japan, University of Alberta, Bart's and The London School of Medicine and Dentistry, Mayo Clinic College of Medicine, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Liver Unit, Clínica Universitaria, CIBER-EHD, Clinic Barcelona Hospital Universitari, Service d'Hépato-gastro-entérologie CHRU Nancy, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Inflammatory Bowel Disease Research Center Shanghai, Shanghai Jiao Tong University Shanghai, Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China, The University of Chicago Medicine Chicago, University of California San Diego (UC San Diego), University of California (UC), University Medical Center of Schleswig–Holstein = Universitätsklinikum Schleswig-Holstein (UKSH), Christian-Albrechts-Universität zu Kiel = Christian-Albrechts University of Kiel = Université Christian-Albrechts de Kiel (CAU), Abbvie Inc. North Chicago, AbbVie Deutschland GmbH & Co KG, Abbott GmbH & Co KG, Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven)

المصدر: ISSN: 0140-6736.

مصطلحات موضوعية: MESH: Abdominal Pain, MESH: Antibodies, Monoclonal, MESH: Biological Products, MESH: Crohn Disease, MESH: Humans, MESH: Induction Chemotherapy, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/35644154; PUBMED: 35644154

الاتاحة: https://hal.univ-lorraine.fr/hal-04165754
https://doi.org/10.1016/S0140-6736(22)00467-6

المؤلفون: Sands, Bruce, Peyrin-Biroulet, Laurent, Kierkus, Jaroslaw, Higgins, Peter, Fischer, Monika, Jairath, Vipul, Hirai, Fumihito, d'Haens, Geert, Belin, Ruth, Miller, Debra, Gomez-Valderas, Elisa, Naegeli, April, Tuttle, Jay, Pollack, Paul, Sandborn, William, Higgins, Peter D.R., D’haens, Geert

المساهمون: Service d'Hépato-gastro-entérologie CHRU Nancy, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)

المصدر: ISSN: 0016-5085.

مصطلحات موضوعية: Cytokine, IBD, Inhibitor, MESH: Adult, MESH: Antibodies, Monoclonal, Humanized, MESH: Male, MESH: Middle Aged, MESH: Patient Reported Outcome Measures, MESH: Remission Induction, MESH: Severity of Illness Index, MESH: Treatment Outcome, MESH: Crohn Disease, MESH: Endoscopy, Digestive System, MESH: Female, MESH: Gastrointestinal Agents, MESH: Humans, MESH: Induction Chemotherapy, MESH: Interleukin-23 Subunit p19, MESH: Maintenance Chemotherapy, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/34748774; hal-04214543; https://hal.univ-lorraine.fr/hal-04214543; PUBMED: 34748774

الاتاحة: https://hal.univ-lorraine.fr/hal-04214543
https://doi.org/10.1053/j.gastro.2021.10.050

المؤلفون: Pointreau, Y., Biau, J., Delaby, N., Thariat, J., Lapeyre, M.

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)

المصدر: ISSN: 1278-3218.

مصطلحات موضوعية: Delineation, Dose, Doses, Délinéation, French Society of Radiation Oncology, Hypopharynx cancer, Indication, Indications, Intensity-modulated radiotherapy, Radiothérapie conformationnelle avec modulation d’intensité, Recommandations, Recommendation, Société française de radiothérapie oncologique, Tumeurs hypopharyngée, MESH: Chemoradiotherapy, MESH: Dose Fractionation, Radiation, MESH: Radiotherapy, Intensity-Modulated, MESH: France, MESH: Humans, MESH: Hypopharyngeal Neoplasms, MESH: Induction Chemotherapy, MESH: Laryngectomy, MESH: Lymphatic Irradiation, MESH: Pharyngectomy, MESH: Radiation Oncology, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/34953703; hal-03889542; https://hal.science/hal-03889542; PUBMED: 34953703

الاتاحة: https://hal.science/hal-03889542
https://doi.org/10.1016/j.canrad.2021.10.006

المؤلفون: Biau, J., Pointreau, Y., Blanchard, P., Khampan, C., Giraud, P., Lapeyre, M., Maingon, P.

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)

المصدر: ISSN: 1278-3218.

مصطلحات موضوعية: Delineation, Dose, Doses, Délinéation, Indication, Indications, Intensity-modulated radiotherapy, Larynx cancer, Radiothérapie conformationnelle avec modulation d’intensité, Recommandations, Recommendations, Société française de radiothérapie oncologique, Tumeurs laryngée, MESH: Cisplatin, MESH: Dose Fractionation, Radiation, MESH: Radiation Oncology, MESH: Radiation-Sensitizing Agents, MESH: Radiotherapy, Image-Guided, Intensity-Modulated, MESH: Tomography, X-Ray Computed, MESH: France, MESH: Humans, MESH: Induction Chemotherapy, MESH: Laryngeal Neoplasms, MESH: Laryngectomy, MESH: Neoplasm Staging, MESH: Organ Sparing Treatments

Relation: info:eu-repo/semantics/altIdentifier/pmid/34953705; hal-03889481; https://hal.science/hal-03889481; PUBMED: 34953705

الاتاحة: https://hal.science/hal-03889481
https://doi.org/10.1016/j.canrad.2021.09.004

المؤلفون: Lere-Chevaleyre, Alexane, Bernadach, Maureen, Lambert, Céline, Cassagnes, Lucie, Puechmaille, Mathilde, Mom, Thierry, Gilain, Laurent, Lapeyre, Michel, Boirie, Yves, Biau, Julian, Saroul, Nicolas

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)

المصدر: ISSN: 1043-3074.

مصطلحات موضوعية: body composition, chemo-toxicity, head and neck cancer, muscular mass, nutritional status, taxotere-platine-fluorouracil, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Cisplatin, MESH: Docetaxel, MESH: Fluorouracil, MESH: Head and Neck Neoplasms, MESH: Humans, MESH: Induction Chemotherapy, MESH: Muscle, Skeletal, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/34918416; hal-03889561; https://hal.science/hal-03889561; PUBMED: 34918416

الاتاحة: https://hal.science/hal-03889561
https://doi.org/10.1002/hed.26954

المؤلفون: J. Biau, Y. Pointreau, P. Blanchard, C. Khampan, P. Giraud, M. Lapeyre, P. Maingon

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)

المصدر: Cancer/Radiothérapie
Cancer/Radiothérapie, 2022, 26 (1-2), pp.206-212. ⟨10.1016/j.canrad.2021.09.004⟩

مصطلحات موضوعية: MESH: Radiation-Sensitizing Agents, Radiation-Sensitizing Agents, Intensity-modulated radiotherapy, Recommandations, MESH: Laryngeal Neoplasms, Laryngectomy, [SDV.CAN]Life Sciences [q-bio]/Cancer, Radiothérapie conformationnelle avec modulation d’intensité, Recommendations, MESH: Postoperative Care, Doses, Délinéation, Humans, Radiology, Nuclear Medicine and imaging, Laryngeal Neoplasms, Neoplasm Staging, Postoperative Care, MESH: Humans, MESH: Organ Sparing Treatments, Larynx cancer, Induction Chemotherapy, Delineation, MESH: Radiotherapy, Intensity-Modulated, MESH: Neoplasm Staging, MESH: Laryngectomy, MESH: Radiation Oncology, MESH: Induction Chemotherapy, Indication, MESH: France, Tumeurs laryngée, Oncology, MESH: Cisplatin, Dose, Radiation Oncology, Dose Fractionation, Radiation, France, Radiotherapy, Intensity-Modulated, Cisplatin, Indications, MESH: Dose Fractionation, Radiation, Tomography, X-Ray Computed, MESH: Tomography, X-Ray Computed, Organ Sparing Treatments, MESH: Radiotherapy, Image-Guided, Radiotherapy, Image-Guided, Société française de radiothérapie oncologique

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f072f9af021c2fc02817497d79f37bd4
https://hal.archives-ouvertes.fr/hal-03889481

المؤلفون: Schmaltz, H, Borel, C, Ciftci, Saït, Takeda-Raguin, C, Debry, Christian, Schultz, P, Dupret-Bories, A

المساهمون: Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Centre Paul Strauss (CRLCC Paul Strauss), UNICANCER, Biomatériaux et Bioingénierie (BB), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Matériaux et Nanosciences Grand-Est (MNGE), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: ISSN: 1781-782X.

مصطلحات موضوعية: MESH: Adult, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Head and Neck Neoplasms, MESH: Humans, MESH: Induction Chemotherapy, MESH: Male, MESH: Middle Aged, MESH: Mouth Neoplasms, MESH: Oropharyngeal Neoplasms, MESH: Paclitaxel, MESH: Retrospective Studies, MESH: Squamous Cell Carcinoma of Head and Neck, MESH: Carboplatin, MESH: Taxoids, MESH: Treatment Outcome, MESH: Carcinoma, Squamous Cell, MESH: Cetuximab, MESH: Cisplatin, MESH: Cohort Studies, MESH: Disease-Free Survival, MESH: Female, MESH: Fluorouracil, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/27097391; PUBMED: 27097391

الاتاحة: https://hal.science/hal-03439029
https://hal.science/hal-03439029v1/document
https://hal.science/hal-03439029v1/file/2016-12-1-029-Schmaltz.pdf

المؤلفون: Ignatiadis, Michail, Zardavas, Dimitrios, Lemort, Marc, Wilke, Celine, Vanderbeeken, Marie-Catherine, d'Hondt, Veronique, de Azambuja, Evandro, Gombos, Andrea, Lebrun, Fabienne, Dal Lago, Lissandra, Bustin, Fanny, Maetens, Marion, Ameye, Lieveke, Veys, Isabelle, Michiels, Stefan, Paesmans, Marianne, Larsimont, Denis, Sotiriou, Christos, Nogaret, Jean-Marie, Piccart, Martine, Awada, Ahmad

المساهمون: Clinique d'Oncologie Médicale Brussels, Belgium, Université libre de Bruxelles (ULB)-Institut Jules Bordet Bruxelles, Faculté de Médecine Bruxelles (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB)-Faculté de Médecine Bruxelles (ULB), Université libre de Bruxelles (ULB), Laboratoire de recherche translationnelle sur le cancer du sein Brussels, Belgium, Breast International Group Brussels, Belgium (BIG aisbl), Département de Radiologie Brussels, Belgium (ULB), Medigene AG Planegg, Germany, Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique Gustave Roussy, Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Méthodologie et épidémiologie clinique en oncologie moléculaire (U1018 (Équipe 2)), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR), IJB was the sponsor of this study and Medigene AG provided the EndoTAG-1 and an educational grant. Medigene AG provided support in the form of salaries for author CW.

المصدر: ISSN: 1932-6203.

مصطلحات موضوعية: MESH: Adult, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Biomarkers, Tumor, MESH: Breast Neoplasms, MESH: Combined Modality Therapy, MESH: Cyclophosphamide, MESH: Epirubicin, MESH: Female, MESH: Fluorouracil, MESH: Humans, MESH: Induction Chemotherapy, MESH: Magnetic Resonance Imaging, MESH: Middle Aged, MESH: Neoplasm Grading, MESH: Neoplasm Staging, MESH: Paclitaxel, MESH: Receptor, ErbB-2, MESH: Treatment Outcome, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/27454930; hal-02296718; https://hal.umontpellier.fr/hal-02296718; https://hal.umontpellier.fr/hal-02296718/document; https://hal.umontpellier.fr/hal-02296718/file/journal.pone.0154009.PDF; PUBMED: 27454930; PUBMEDCENTRAL: PMC4959730

الاتاحة: https://hal.umontpellier.fr/hal-02296718
https://hal.umontpellier.fr/hal-02296718/document
https://hal.umontpellier.fr/hal-02296718/file/journal.pone.0154009.PDF
https://doi.org/10.1371/journal.pone.0154009

المؤلفون: Pointreau, Y., Biau, J., Delaby, N., Thariat, J., Lapeyre, M.

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)

المصدر: Cancer/Radiothérapie
Cancer/Radiothérapie, 2022, 26 (1-2), pp.199-205. ⟨10.1016/j.canrad.2021.10.006⟩

مصطلحات موضوعية: MESH: Hypopharyngeal Neoplasms, MESH: Pharyngectomy, Intensity-modulated radiotherapy, Recommandations, French Society of Radiation Oncology, Hypopharynx cancer, [SDV.CAN]Life Sciences [q-bio]/Cancer, Laryngectomy, Radiothérapie conformationnelle avec modulation d’intensité, Doses, Pharyngectomy, Délinéation, MESH: Lymphatic Irradiation, Humans, Radiology, Nuclear Medicine and imaging, MESH: Chemoradiotherapy, MESH: Humans, Hypopharyngeal Neoplasms, Lymphatic Irradiation, Tumeurs hypopharyngée, Delineation, MESH: Radiotherapy, Intensity-Modulated, Chemoradiotherapy, Induction Chemotherapy, Recommendation, MESH: Laryngectomy, MESH: Induction Chemotherapy, MESH: Radiation Oncology, Indication, MESH: France, Oncology, Dose, Radiation Oncology, Dose Fractionation, Radiation, France, Radiotherapy, Intensity-Modulated, Indications, MESH: Dose Fractionation, Radiation, Société française de radiothérapie oncologique

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426a61dab6a348fb01d0aedc94472bc4
https://pubmed.ncbi.nlm.nih.gov/34953703

المؤلفون: Schmaltz H, Borel C, Ciftci S, Takeda-Raguin C, Debry C, Schultz P, Agnès Dupret-Bories

المساهمون: Biomatériaux et Bioingénierie (BB), Université de Strasbourg (UNISTRA)-Matériaux et nanosciences d'Alsace (FMNGE), Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), univOAK, Archive ouverte

المصدر: B-ENT
B-ENT, 2021, 12 (1), pp.29-32
ResearcherID
Europe PubMed Central

مصطلحات موضوعية: Adult, Male, Paclitaxel, MESH: Taxoids, Cetuximab, [SDV.CAN]Life Sciences [q-bio]/Cancer, Disease-Free Survival, Carboplatin, Cohort Studies, MESH: Mouth Neoplasms, MESH: Cetuximab, [SDV.CAN] Life Sciences [q-bio]/Cancer, MESH: Carboplatin, Antineoplastic Combined Chemotherapy Protocols, Humans, MESH: Squamous Cell Carcinoma of Head and Neck, MESH: Paclitaxel, MESH: Cohort Studies, Retrospective Studies, MESH: Treatment Outcome, MESH: Humans, MESH: Middle Aged, Squamous Cell Carcinoma of Head and Neck, MESH: Adult, MESH: Retrospective Studies, MESH: Carcinoma, Squamous Cell, Induction Chemotherapy, Middle Aged, MESH: Induction Chemotherapy, MESH: Male, MESH: Head and Neck Neoplasms, Oropharyngeal Neoplasms, MESH: Antineoplastic Combined Chemotherapy Protocols, Treatment Outcome, MESH: Oropharyngeal Neoplasms, MESH: Cisplatin, Head and Neck Neoplasms, MESH: Disease-Free Survival, Carcinoma, Squamous Cell, Female, Mouth Neoplasms, Taxoids, Fluorouracil, Cisplatin, MESH: Female, MESH: Fluorouracil

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b8d339d7f4d1efffb3bc64236ad5fa7c
https://hal.archives-ouvertes.fr/hal-03439029

المؤلفون: Alexane Lere‐Chevaleyre, Maureen Bernadach, Céline Lambert, Lucie Cassagnes, Mathilde Puechmaille, Thierry Mom, Laurent Gilain, Michel Lapeyre, Yves Boirie, Julian Biau, Nicolas Saroul

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), CHU Clermont-Ferrand, Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI), Unité de Nutrition Humaine (UNH), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Clermont Auvergne (UCA)

المصدر: Head & Neck
Head & Neck, 2022, 44 (3), pp.681-690. ⟨10.1002/hed.26954⟩
Head & Neck, Wiley, 2022, 44 (3), pp.681-690. ⟨10.1002/hed.26954⟩

مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, Docetaxel, parasitic diseases, Antineoplastic Combined Chemotherapy Protocols, Humans, Muscle, Skeletal, MESH: Docetaxel, body composition, MESH: Muscle, Skeletal, MESH: Humans, Induction Chemotherapy, MESH: Induction Chemotherapy, nutritional status, MESH: Head and Neck Neoplasms, MESH: Antineoplastic Combined Chemotherapy Protocols, Otorhinolaryngology, MESH: Cisplatin, chemo-toxicity, Head and Neck Neoplasms, muscular mass, head and neck cancer, Fluorouracil, Cisplatin, taxotere-platine-fluorouracil, MESH: Fluorouracil

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab1022a70ba3ac254d1195313be3946d
https://pubmed.ncbi.nlm.nih.gov/34918416

المؤلفون: Lucy Smyth, Andrea Mazzetti, Charles D. Pusey, Lorraine Harper, Donna Reidlinger, Gina Gregorini, William F. Clark, Pexivas Investigators Pexivas Investigators, Adeera Levin, Toshiko Ito-Ihara, Chen-Au Peh, Xavier Puéchal, Ulrich Specks, Carmel M. Hawley, Oliver Floßmann, Simon Carette, Alina Casian, Wojciech Szczeklik, Peter A. Merkel, Janak de Zoysa, Nader Khalidi, David Jayne, Samir Mehta, Biljana Brezina, Ron Wald, Michael Walsh, Luis Felipe Flores-Suárez, Carol A. McAlear, L. Guillevin, Louis Girard, Natalie Ives, Wladimir Szpirt, Vladimir Tesar, Elizabeth Broadhurst, Christian Pagnoux, Shouichi Fujimoto

المساهمون: McMaster University [Hamilton, Ontario], Royal Adelaide Hospital [Adelaide Australia], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Miyazaki, McMaster University, St. Joseph’s Healthcare, Royal Berkshire Hospital, St. Michael's Hospital, University of British Columbia (UBC), Università degli Studi di Brescia [Brescia], Mount Sinai Hospital [Toronto, Canada] (MSH), Mayo Clinic [Rochester], Charles University [Prague] (CU), Instituto Nacional de Enfermedades Respiratorias [México, Mexico], University of Cambridge [UK] (CAM), Addenbrooke's Hospital, Cambridge University NHS Trust

المصدر: Walsh, M, Merkel, P A, Peh, C, Szpirt, W M, Puéchal, X, Fujimoto, S, Hawley, C M, Khalidi, N, Floßmann, O, Wald, R, Girard, L P, Levin, A, Gregorini, G, Harper, L, Clark, W F, Pagnoux, C, Specks, U, Smyth, L, Tesar, V, Ito-ihara, T, De Zoysa, J R, Szczeklik, W, Flores-suárez, L F, Carette, S, Guillevin, L, Pusey, C D, Casian, A L, Brezina, B, Mazzetti, A, Mcalear, C A, Broadhurst, E, Reidlinger, D, Mehta, S, Ives, N & Jayne, D R W 2020, ' Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis ', New England Journal of Medicine, vol. 382, no. 7, pp. 622-631 . https://doi.org/10.1056/NEJMoa1803537
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2020, 382 (7), pp.622-631. ⟨10.1056/NEJMoa1803537⟩

مصطلحات موضوعية: MESH: Combined Modality Therapy, medicine.medical_specialty, Cyclophosphamide, medicine.medical_treatment, Azathioprine, 030204 cardiovascular system & hematology, urologic and male genital diseases, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, Gastroenterology, MESH: Dose-Response Relationship, Drug, MESH: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, 03 medical and health sciences, 0302 clinical medicine, Maintenance therapy, immune system diseases, Internal medicine, Medicine, MESH: Incidence, cardiovascular diseases, 030212 general & internal medicine, skin and connective tissue diseases, Anti-neutrophil cytoplasmic antibody, MESH: Aged, MESH: Kidney Diseases, MESH: Middle Aged, MESH: Humans, business.industry, MESH: Cyclophosphamide, MESH: Adult, Glomerulonephritis, General Medicine, MESH: Plasma Exchange, medicine.disease, MESH: Induction Chemotherapy, MESH: Male, respiratory tract diseases, 3. Good health, MESH: Kidney Failure, Chronic, MESH: Administration, Oral, Rituximab, Plasmapheresis, MESH: Immunosuppressive Agents, MESH: Rituximab, MESH: Glucocorticoids, business, Vasculitis, MESH: Female, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff53a8321bbaae6bb5cf637d8d822ce
https://doi.org/10.1056/nejmoa1803537

المؤلفون: Jérémie Rouger-Gaudichon, Yves Bertrand, Nicolas Boissel, Benoit Brethon, Stéphane Ducassou, Virginie Gandemer, Carine Halfon-Domenech, Thierry Leblanc, Guy Leverger, Gérard Michel, Arnaud Petit, Anne-France Ray-Lunven, Pierre-Simon Rohrlich, Pascale Schneider, Nicolas Sirvent, Marion Strullu, André Baruchel

المساهمون: Institut de Génétique et Développement de Rennes (IGDR), Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Hospices Civils de Lyon (HCL), Hôpital Robert Debré Paris, Hôpital Robert Debré, CHU Bordeaux [Bordeaux], CHU Pontchaillou [Rennes], CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital de la Timone [CHU - APHM] (TIMONE), Centre Hospitalier Universitaire de Nice (CHU Nice), Service d'hémato-immuno-oncologie pédiatrique [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM)

المصدر: Bulletin du Cancer
Bulletin du Cancer, 2021, 108 (5), pp.490-500. ⟨10.1016/j.bulcan.2021.02.004⟩

مصطلحات موضوعية: Cancer Research, COVID19, MESH: Drug Interactions, MESH: Consolidation Chemotherapy, Acute lymphoblastic leukemia, Adolescents, MESH: Risk Assessment, MESH: Cancer Care Facilities, Adrenal Cortex Hormones, Recurrence, hemic and lymphatic diseases, MESH: Child, MESH: COVID-19, Drug Interactions, MESH: Adenosine Monophosphate, Child, Acute lymphoblastic leukemia-children-adolescents, Children, Societies, Medical, Alanine, Induction Chemotherapy, Hematology, General Medicine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, MESH: Induction Chemotherapy, MESH: Maintenance Chemotherapy, Oncology, MESH: COVID-19 Vaccines, COVID-19 Nucleic Acid Testing, France, COVID 19, MESH: Antiviral Agents, COVID-19 Vaccines, Adolescent, MESH: Alanine, MESH: Societies, Medical, [SDV.CAN]Life Sciences [q-bio]/Cancer, Cancer Care Facilities, Antiviral Agents, Risk Assessment, MESH: COVID-19 Nucleic Acid Testing, Maintenance Chemotherapy, MESH: Adrenal Cortex Hormones, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Humans, Radiology, Nuclear Medicine and imaging, MESH: Adolescent, MESH: Precursor Cell Lymphoblastic Leukemia-Lymphoma, MESH: Humans, SARS-CoV-2, COVID-19, Synthèse, Adenosine Monophosphate, COVID-19 Drug Treatment, MESH: Recurrence, Consolidation Chemotherapy, MESH: France, MESH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leucémie aiguë lymphoblastique-enfants-adolescents

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e77e99033d737d9e0374c1e4947a23
http://europepmc.org/articles/PMC7951944

المؤلفون: Reinisch, Walter, Gecse, Krisztina, Halfvarson, Jonas, Irving, Peter, Jahnsen, Jørgen, Peyrin-Biroulet, Laurent, Rogler, Gerhard, Schreiber, Stefan, Danese, Silvio

المساهمون: Medizinische Universität Wien = Medical University of Vienna, Amsterdam University Medical Centers (Amsterdam UMC), Örebro University, Guy's and St Thomas' NHS Foundation Trust, University of Oslo (UiO), Akershus University Hospital Lørenskog, Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service d'Hépato-gastro-entérologie CHRU Nancy, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Universität Zürich Zürich = University of Zurich (UZH), University hospital of Zurich Zurich, Christian-Albrechts-Universität zu Kiel = Christian-Albrechts University of Kiel = Université Christian-Albrechts de Kiel (CAU), University Medical Center of Schleswig–Holstein = Universitätsklinikum Schleswig-Holstein (UKSH), Humanitas Clinical and Research Center Rozzano, Milan, Italy, Humanitas University Milan (Hunimed)

المصدر: ISSN: 1078-0998.

مصطلحات موضوعية: biomarkers, clinical trials, endoscopy, MESH: Adalimumab, MESH: Biosimilar Pharmaceuticals, MESH: Tumor Necrosis Factor Inhibitors, MESH: Crohn Disease, MESH: Humans, MESH: Induction Chemotherapy, MESH: Infliximab, MESH: Patient Selection, MESH: Practice Guidelines as Topic, MESH: Severity of Illness Index, MESH: Treatment Outcome, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/32634212; PUBMED: 32634212; PUBMEDCENTRAL: PMC7737159

الاتاحة: https://hal.univ-lorraine.fr/hal-04214789
https://doi.org/10.1093/ibd/izaa078

المؤلفون: Schmaltz, H, Borel, C, Ciftci, Saït, Takeda-Raguin, C, Debry, Christian, Schultz, P, Dupret-Bories, A

المساهمون: Biomatériaux et Bioingénierie (BB), Université de Strasbourg (UNISTRA)-Matériaux et nanosciences d'Alsace (FMNGE), Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: B-ENT ; https://hal.archives-ouvertes.fr/hal-03439029 ; B-ENT, 2021, 12 (1), pp.29-32

مصطلحات موضوعية: MESH: Adult, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Head and Neck Neoplasms, MESH: Humans, MESH: Induction Chemotherapy, MESH: Male, MESH: Middle Aged, MESH: Mouth Neoplasms, MESH: Oropharyngeal Neoplasms, MESH: Paclitaxel, MESH: Retrospective Studies, MESH: Squamous Cell Carcinoma of Head and Neck, MESH: Carboplatin, MESH: Taxoids, MESH: Treatment Outcome, MESH: Carcinoma, Squamous Cell, MESH: Cetuximab, MESH: Cisplatin, MESH: Cohort Studies, MESH: Disease-Free Survival, MESH: Female, MESH: Fluorouracil, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/27097391; hal-03439029; https://hal.archives-ouvertes.fr/hal-03439029; PUBMED: 27097391

الاتاحة: https://hal.archives-ouvertes.fr/hal-03439029

المؤلفون: Walsh, Michael, Merkel, Peter, Peh, Chen-Au, Szpirt, Wladimir, Puéchal, Xavier, Fujimoto, Shouichi, Hawley, Carmel, Khalidi, Nader, Flossmann, Oliver, Wald, Ron, Girard, Louis, Levin, Adeera, Gregorini, Gina, Harper, Lorraine, Clark, William, Pagnoux, Christian, Specks, Ulrich, Smyth, Lucy, Tesar, Vladimir, Ito-Ihara, Toshiko, de Zoysa, Janak Rashme, Szczeklik, Wojciech, Flores-Suárez, Luis Felipe, Carette, Simon, Guillevin, Loïc, Pusey, Charles, Casian, Alina, Brezina, Biljana, Mazzetti, Andrea, Mcalear, Carol, Broadhurst, Elizabeth, Reidlinger, Donna, Mehta, Samir, Ives, Natalie, Jayne, David R.W.

المساهمون: McMaster University Hamilton, Ontario, Royal Adelaide Hospital Adelaide Australia, Hôpital Cochin AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Miyazaki, McMaster University, St. Joseph’s Healthcare, Royal Berkshire Hospital, St. Michael's Hospital, University of British Columbia (UBC), Università degli Studi di Brescia = University of Brescia (UniBs), Mount Sinai Hospital Toronto, Canada (MSH), Mayo Clinic Rochester, Univerzita Karlova Praha, Česká republika = Charles University Prague, Czech Republic (UK), Instituto Nacional de Enfermedades Respiratorias México, Mexico, University of Cambridge UK (CAM), Addenbrooke's Hospital, Cambridge University NHS Trust

المصدر: ISSN: 0028-4793.

مصطلحات موضوعية: MESH: Administration, Oral, MESH: Adult, MESH: Immunosuppressive Agents, MESH: Incidence, MESH: Induction Chemotherapy, MESH: Kidney Diseases, MESH: Kidney Failure, Chronic, MESH: Male, MESH: Middle Aged, MESH: Plasma Exchange, MESH: Rituximab, MESH: Aged, MESH: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, MESH: Combined Modality Therapy, MESH: Cyclophosphamide, MESH: Dose-Response Relationship, Drug, MESH: Female, MESH: Glucocorticoids, MESH: Humans, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology

Relation: info:eu-repo/semantics/altIdentifier/pmid/32053298; hal-03514675; https://hal.umontpellier.fr/hal-03514675; PUBMED: 32053298; PUBMEDCENTRAL: PMC7325726

الاتاحة: https://hal.umontpellier.fr/hal-03514675
https://doi.org/10.1056/NEJMoa1803537